CLINICAL_TRIALS
trial_result
· 2026-03-24
Clinical Trial Update: Long Term Follow-up for RGX-202
Summary
A clinical trial update on long-term follow-up for RGX-202 in Duchenne Muscular Dystrophy, with enrollment by invitation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: REGENXBIO Inc. | Conditions: Duchenne Muscular Dystrophy | Status: ENROLLING_BY_INVITATION